% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • drmrreddy drmrreddy May 9, 2012 1:03 PM Flag

    •Phase III protocol for endometriosis finalized

    Current Elagolix Endometriosis Activities
    •Phase III protocol for endometriosis finalized
    »Endpoints – non-menstrual pelvic pain and dysmenorrhea
    »Statistical Methods – responder analysis
    »Trial Design – Two trials, placebo controlled, six-months in duration, safety extension to one year
    •Investigator meeting held April 2012
    •Patient screening begins in May 2012
    •Market research
    »Qualitative/Quantitative Research

    SortNewest  |  Oldest  |  Most Replied Expand all replies
49.54+0.60(+1.23%)Aug 26 4:00 PMEDT